CRON - Cronos Group Inc.

2.73
-0.030   -1.099%

Share volume: 1,460,413
Last Updated: 04-21-2026
Pharmaceutical Products/Medicinal Chemicals: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$2.76
-0.03
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
84%
Profitability 78%
Dept financing 50%
Liquidity 75%
Performance 100%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.49%
1 Month
8.33%
3 Months
1.87%
6 Months
13.28%
1 Year
54.24%
2 Year
15.68%
Key data
Stock price
$2.73
P/E Ratio 
0.00
DAY RANGE
$2.69 - $2.77
EPS 
-$0.02
52 WEEK RANGE
$1.78 - $3.43
52 WEEK CHANGE
$52.51
MARKET CAP 
1.007 B
YIELD 
N/A
SHARES OUTSTANDING 
379.051 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,182,849
AVERAGE 30 VOLUME 
$961,480
Company detail
CEO: Michael R. Gorenstein
Region: US
Website: thecronosgroup.com
Employees: 450
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for medical and adult-use markets.

Recent news